Browse > Article
http://dx.doi.org/10.3347/kjp.2022.60.2.143

Specific Detection of Acanthamoeba species using Polyclonal Peptide Antibody Targeting the Periplasmic Binding Protein of A. castellanii  

Kim, Min-Jeong (Department of Biomedical Science, Graduate School, Kyung Hee University)
Quan, Fu-Shi (Department of Medical Zoology, Kyung Hee University School of Medicine)
Kong, Hyun-Hee (Department of Parasitology, Dong-A University College of Medicine)
Kim, Jong-Hyun (Institute of Animal Medicine, College of Veterinary Medicine, Gyeongsang National University)
Moon, Eun-Kyung (Department of Medical Zoology, Kyung Hee University School of Medicine)
Publication Information
Parasites, Hosts and Diseases / v.60, no.2, 2022 , pp. 143-147 More about this Journal
Abstract
Acanthamoeba keratitis (AK) is a rare ocular disease, but it is a painful and sight-threatening infectious disease. Early diagnosis and adequate treatment are necessary to prevent serious complications. While AK is frequently diagnosis via several PCR assays or Acanthamoeba-specific antibodies, a more specific and effective diagnostic method is required. This study described the production of a polyclonal peptide antibody against the periplasmic binding protein (PBP) of A. castellanii and investigated its diagnostic potential. Western blot analysis showed that the PBP antibody specifically reacted with the cell lysates of A. castellanii. However, the PBP antibody did not interact with human corneal epithelial (HCE) cells and the other 3 major causative agents of keratitis. Immunocytochemistry (ICC) results revealed the specific detection of A. castellanii trophozoites and cysts by PBP antibodies when A. castellanii were co-cultured with HCE cells. PBP antibody specificity was further confirmed by co-culture of A. castellanii trophozoites with F. solani, S. aureus, and P. aeruginosa via ICC. The PBP antibody specifically reacted with the trophozoites and cysts of A. polyphaga, A. hatchetti, A. culbertsoni, A. royreba, and A. healyi, thus demonstrated its genus-specific nature. These results showed that the PBP polyclonal peptide antibody of A. castellanii could specifically detect several species of Acanthamoeba, contributing to the development of an effective antibody-based AK diagnostics.
Keywords
Acanthamoeba keratitis; periplasmic binding protein; peptide antibody; species specificity;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Ko W, Kim S, Lee HS. Engineering a periplasmic binding protein for amino acid sensors with improved binding properties. Org Biomol Chem 2017; 15: 8761-8769. https://doi.org/10.1039/C7OB02165H   DOI
2 Moon EK, Choi HS, Park SM, Kong HH, Quan FS. Comparison of proteins secreted into extracellular space of pathogenic and non-pathogenic Acanthamoeba castellanii. Korean J Parasitol 2018; 56: 553-558. https://doi.org/10.3347/kjp.2018.56.6.553   DOI
3 Edwards KA, Randall EA, Tu-Maung N, Sannino DR, Feder S, Angert ER, Kraft CE. Periplasmic binding protein-based magnetic isolation and detection of thiamine in complex biological matrices. Talanta 2019; 205: 120168. https://doi.org/10.1016/j.talanta.2019.120168   DOI
4 Edwards KA, Baeumner AJ. Periplasmic binding protein-based detection of maltose using liposomes: a new class of biorecognition elements in competitive assays. Anal Chem 2013; 85: 2770-2778. https://doi.org/10.1021/ac303258n   DOI
5 Baek M, DiMaio F, Anishchenko I, Dauparas J, Ovchinnikov S, Lee GR, Wang J, Cong Q, Kinch LN, Schaeffer RD, Millan C, Park H, Adams C, Glassman CR, DeGiovanni A, Pereira JH, Rodrigues AV, van Dijk AA, Ebrecht AC, Opperman DJ, Sagmeister T, Buhlheller C, Pavkov-Keller T, Rathinaswamy MK, Dalwadi U, Yip CK, Burke JE, Garcia KC, Grishin NV, Adams PD, Read RJ, Baker D. Accurate prediction of protein structures and interactions using a three-track neural network. Science 2021; 373: 871-876. https://doi.org/10.1126/science.abj8754   DOI
6 Maycock NJ, Jayaswal R. Update on Acanthamoeba keratitis: diagnosis, treatment, and outcomes. Cornea 2016; 35: 713-720. https://doi.org/10.1097/ICO.0000000000000804   DOI
7 Moon EK, Xuan YH, Kong HH. Microarray and KOG analysis of Acanthamoeba healyi genes up-regulated by mouse-brain passage. Exp Parasitol 2014; 143: 69-73. https://doi.org/10.1016/j.exppara.2014.05.012   DOI
8 Marciano-Cabral F, Cabral G. Acanthamoeba spp. as agents of disease in humans. Clin Microbiol Rev 2003; 16: 273-307. https://doi.org/10.1128/CMR.16.2.273-307.2003   DOI
9 Schuster FL, Visvesvara GS. Free-living amoebae as opportunistic and non-opportunistic pathogens of humans and animals. Int J Parasitol 2004; 34: 1001-1027. https://doi.org/10.1016/j.ijpara.2004.06.004   DOI
10 Singh A, Sahu SK, Sharma S, Das S. Acanthamoeba keratitis versus mixed acanthamoeba and bacterial keratitis: comparison of clinical and microbiological profiles. Cornea 2020; 39: 1112-1116. https://doi.org/10.1097/ICO.0000000000002337   DOI
11 Maubon D, Dubosson M, Chiquet C, Yera H, Brenier-Pinchart MP, Cornet M, Savy O, Renard E, Pelloux H. A one-step multiplex PCR for acanthamoeba keratitis diagnosis and quality samples control. Invest Ophthalmol Vis Sci 2012; 53: 2866-2872. https://doi.org/10.1167/iovs.11-8587   DOI
12 Laummaunwai P, Ruangjirachuporn W, Boonmars T. A simple PCR condition for detection of a single cyst of Acanthamoeba species. Parasitol Res 2012; 110: 1569-1572. doi: 10.1007/s00436-011-2662-3   DOI
13 Weber-Lima MM, Prado-Costa B, Becker-Finco A, Costa AO, Billilad P, Furst C, de Moura JF, Alvarenga LM. Acanthamoeba spp. monoclonal antibody against a CPA2 transporter: a promising molecular tool for acanthamoebiasis diagnosis and encystment study. Parasitology 2020; 147: 1678-1688. https://doi.org/10.1017/S0031182020001778   DOI
14 Page MA, Mathers WD. Acanthamoeba keratitis: a 12-year experience covering a wide spectrum of presentations, diagnoses, and outcomes. J Ophthalmol 2013; 2013: 670242. https://doi.org/10.1155/2013/670242   DOI
15 Park SM, Lee HA, Chu KB, Quan FS, Kim SJ, Moon EK. Production of a polyclonal antibody against inosine-uridine preferring nucleoside hydrolase of Acanthamoeba castellanii and its access to diagnosis of Acanthamoeba keratitis. PLoS One 2020; 15: e0239867. https://doi.org/10.1371/journal.pone.0239867   DOI
16 Lee HA, Chu KB, Kim MJ, Quan FS, Kong HH, Moon EK. Chorismate mutase peptide antibody enables specific detection of Acanthamoeba. PLoS One 2021; 16: e0250342. https://doi.org/10.1371/journal.pone.0250342   DOI
17 Raghavan A, Baidwal S, Venkatapathy N, Rammohan R. The Acanthamoeba-fungal keratitis study. Am J Ophthalmol 2019; 201: 31-36. https://doi.org/10.1016/j.ajo.2019.01.024   DOI
18 Yera H, Ok V, Lee Koy Kuet F, Dahane N, Ariey F, Hasseine L, Delaunay P, Martiano D, Marty P, Bourges JL. PCR and culture for diagnosis of Acanthamoeba keratitis. Br J Ophthalmol 2021; 105: 1302-1306. http://dx.doi.org/10.1136/bjophthalmol-2020-316730   DOI
19 Rasheed AK, Siddiqui R, Ahmed SMK, Gabriel S, Jalal MZ, John A, Khan NA. hBN nanoparticle-assisted rapid thermal cycling for the detection of Acanthamoeba. Pathogens 2020; 9: 824. https://doi.org/10.3390/pathogens9100824   DOI
20 Turner ML, Cockerell EJ, Brereton HM, Badenoch PR, Tea M, Coster DJ, Williams KA. Antigens of selected Acanthamoeba species detected with monoclonal antibodies. Int J Parasitol 2005; 35: 981-990. https://doi.org/10.1016/j.ijpara.2005.03.015   DOI
21 Fanselow N, Sirajuddin N, Yin XT, Huang AJW, Stuart PM. Acanthamoeba keratitis, pathology, diagnosis and treatment. Pathogens 2021; 10: 323. https://doi.org/10.3390/pathogens10030323   DOI
22 Kang AY, Park AY, Shin HJ, Khan NA, Maciver SK, Jung SY. Production of a monoclonal antibody against a mannose-binding protein of Acanthamoeba culbertsoni and its localization. Exp Parasitol 2018; 192: 19-24. https://doi.org/10.1016/j.exppara.2018.07.009   DOI